91Ë¿¹ÏÊÓÆµ

Fackson Mwale

Academic title(s): 
  • Professor, Department of Surgery (Orthopaedic Surgery)
  • James 91Ë¿¹ÏÊÓÆµ Professor
  • Graduate Program Director Chair
  • Graduate Executive Committee
Fackson Mwale
Contact Information
Email address: 
fackson.mwale [at] mcgill.ca
Phone: 
514-668-4300
Courses: 
  • EXSU 501 Medical Technology Internship 1
  • EXSU 502 Medical Technology Internship 2
  • EXSU 619 The Hospital Environment 
  • EXSU 620 Surgical Innovation 1 
Location: 
Lady Davies Institute for Medical Research - SMBD - Jewish General Hospital
Office: 
Room F-602
Division: 
Orthopaedics
Hospital title: 
Senior Investigator, Lady Davis Institute for Medical Research
Degree(s): 

PhD, Biochemistry – University of South Carolina, USA

Awards, honours, and fellowships: 

James 91Ë¿¹ÏÊÓÆµ Professor and William Dawson Scholar

Post-Doctoral Research Fellowship
91Ë¿¹ÏÊÓÆµ
Montreal, Quebec, Canada
3 Years

Research Associate
91Ë¿¹ÏÊÓÆµ
Montreal, Quebec, Canada
3 Years

Current research: 

Dr. Mwale’s research focuses on musculoskeletal biology and translational strategies for intervertebral disc degeneration and osteoarthritis, with emphasis on biologically driven therapeutics, inflammatory and pain-related signaling pathways, and bench-to-clinic translation.

Clinical Interests: 

Musculoskeletal and spinal disorders, Intervertebral disc degeneration Osteoarthritis and chronic pain (research and translational focus)

Language(s) spoken: 
English
French
Spanish
Biography: 

Dr. Fackson Mwale is a Professor in the Department of Surgery (Orthopaedic Surgery) at 91Ë¿¹ÏÊÓÆµ and a James 91Ë¿¹ÏÊÓÆµ Professor. He serves as Graduate Program Director and Chair of the Graduate Executive Committee, providing leadership in graduate education and research training. Dr. Mwale is a Scientist whose research focuses on musculoskeletal biology, intervertebral disc degeneration, osteoarthritis, and pain and inflammatory mechanisms relevant to orthopaedic disease. His work emphasizes biologically driven and translational approaches aimed at developing novel therapeutic strategies for degenerative musculoskeletal conditions. His research has been supported by peer-reviewed funding from the Canadian Institutes of Health Research (CIHR). He has extensive experience in graduate supervision and mentorship and has served in numerous national and international leadership roles, including Co-Chair of the U.S. National Institutes of Health Musculoskeletal Tissue Engineering Study Section and Editorial Board Member for Biomolecules. He is also the founder and CEO of Intervertech Inc., a company established to support translation of novel therapies for intervertebral disc–related low back pain.

Selected publications: 

Follow us on:

Back to top